• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    AxoGen, Inc. (AXGN)

    -NasdaqCM
    3.86 Up 0.06(1.58%) 3:54PM EST
    - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.80
    Open:3.80
    Bid:3.56 x 100
    Ask:3.59 x 100
    1y Target Est:5.38
    Beta:1.39
    Next Earnings Date:N/A
    Day's Range:3.55 - 3.86
    52wk Range:2.11 - 4.68
    Volume:26,741
    Avg Vol (3m):61,158
    Market Cap:75.22M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AXGN

    Comparison

    Symbol% ChgMkt Cap
    AXGNUp 1.58%75.22M
    IARTDown 0.43%1.88B
    JNJDown 0.16%285.79B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.93
    Ex-Dividend Date:27-Jan-10

    Analysts

    Annual EPS Est (Dec-14) :-0.79
    Quarterly EPS Est (Dec-14) :-0.15
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AxoGen, Inc. operates as a medical technology company. It focuses on advancing the science and commercialization of peripheral nerve repair solutions. It offers a range of surgical nerve repair solutions, including Avance Nerve Graft, a processed ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback